$47.36 -1.07 (-2.21%) Mylan Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM
Key Statistics
Last Trade: 47.36
Trade Time: Sep 19 04:00 PM Eastern Daylight Time
Change: -1.07 (-2.21%)
Prev Close: 48.43
Open: 48.67
Bid: 47.35
Ask: 47.36

Competitors

Ticker Name Volume % Change
VVUS Vivus Inc 34.25M +12.37%
PFE Pfizer Inc 25.93M +0.76%
PDLI PDL Biopharma Inc 16.88M -6.96%
AVNR Avanir Pharmaceuticals Inc 11.14M -6.49%
ABBV AbbVie Inc 10.98M -0.29%

MYL Stock Analysis

Partner Headlines

  1. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  2. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  3. US Stock Futures Down Ahead Of Industrial Production Report

    Benzinga | Sep. 15, 2014 | 07:13AM EST
  4. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  5. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  6. Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen

    Benzinga | Sep. 10, 2014 | 07:02AM EST